Manulife (Manufacturers Life Insurance)’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,487
| Closed | -$217K | – | 2970 |
|
|
2024
Q1 | $217K | Buy |
12,487
+11,480
| +1,140% | +$199K | ﹤0.01% | 2561 |
|
|
2023
Q4 | $12.9K | Sell |
1,007
-716
| -42% | -$9.18K | ﹤0.01% | 2950 |
|
|
2023
Q3 | $63.8K | Hold |
1,723
| – | – | ﹤0.01% | 2914 |
|
|
2023
Q2 | $69.4K | Buy |
1,723
+243
| +16% | +$9.78K | ﹤0.01% | 2938 |
|
|
2023
Q1 | $107K | Hold |
1,480
| – | – | ﹤0.01% | 2729 |
|
|
2022
Q4 | $121K | Sell |
1,480
-8
| -0.5% | -$656 | ﹤0.01% | 2750 |
|
|
2022
Q3 | $141K | Buy |
1,488
+1
| +0.1% | +$95 | ﹤0.01% | 2715 |
|
|
2022
Q2 | $290K | Buy |
1,487
+72
| +5% | +$14K | ﹤0.01% | 2421 |
|
|
2022
Q1 | $329K | Sell |
1,415
-337
| -19% | -$78.3K | ﹤0.01% | 2458 |
|
|
2021
Q4 | $690 | Buy |
1,752
+18
| +1% | +$7 | ﹤0.01% | 2057 |
|
|
2021
Q3 | $776K | Sell |
1,734
-129
| -7% | -$57.7K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $724K | Buy |
1,863
+56
| +3% | +$21.8K | ﹤0.01% | 2180 |
|
|
2021
Q1 | $649K | Buy |
1,807
+14
| +0.8% | +$5.03K | ﹤0.01% | 2131 |
|
|
2020
Q4 | $880K | Buy |
1,793
+149
| +9% | +$73.1K | ﹤0.01% | 1893 |
|
|
2020
Q3 | $533K | Buy |
1,644
+268
| +19% | +$86.9K | ﹤0.01% | 1970 |
|
|
2020
Q2 | $476K | Buy |
1,376
+45
| +3% | +$15.6K | ﹤0.01% | 1988 |
|
|
2020
Q1 | $283K | Buy |
1,331
+94
| +8% | +$20K | ﹤0.01% | 2126 |
|
|
2019
Q4 | $509K | Sell |
1,237
-8
| -0.6% | -$3.29K | ﹤0.01% | 2043 |
|
|
2019
Q3 | $419K | Buy |
1,245
+136
| +12% | +$45.8K | ﹤0.01% | 2127 |
|
|
2019
Q2 | $557K | Buy |
1,109
+17
| +2% | +$8.54K | ﹤0.01% | 1981 |
|
|
2019
Q1 | $1.09M | Buy |
1,092
+70
| +7% | +$69.6K | ﹤0.01% | 1645 |
|
|
2018
Q4 | $888K | Sell |
1,022
-67
| -6% | -$58.2K | ﹤0.01% | 1633 |
|
|
2018
Q3 | $1.13M | Sell |
1,089
-110
| -9% | -$114K | ﹤0.01% | 1726 |
|
|
2018
Q2 | $1.1M | Buy |
1,199
+219
| +22% | +$201K | ﹤0.01% | 1806 |
|
|
2018
Q1 | $955K | Buy |
980
+115
| +13% | +$112K | ﹤0.01% | 1867 |
|
|
2017
Q4 | $391K | Buy |
865
+53
| +7% | +$24K | ﹤0.01% | 2486 |
|
|
2017
Q3 | $337K | Sell |
812
-3
| -0.4% | -$1.25K | ﹤0.01% | 2558 |
|
|
2017
Q2 | $285K | Buy |
815
+55
| +7% | +$19.2K | ﹤0.01% | 2721 |
|
|
2017
Q1 | $391K | Buy |
760
+102
| +16% | +$52.5K | ﹤0.01% | 2359 |
|
|
2016
Q4 | $234K | Buy |
658
+1
| +0.2% | +$356 | ﹤0.01% | 2656 |
|
|
2016
Q3 | $352K | Hold |
657
| – | – | ﹤0.01% | 2324 |
|
|
2016
Q2 | $370K | Buy |
657
+194
| +42% | +$109K | ﹤0.01% | 2232 |
|
|
2016
Q1 | $218K | Buy |
463
+8
| +2% | +$3.77K | ﹤0.01% | 2537 |
|
|
2015
Q4 | $300 | Buy |
455
+6
| +1% | +$4 | ﹤0.01% | 2363 |
|
|
2015
Q3 | $353 | Buy |
449
+66
| +17% | +$52 | ﹤0.01% | 2227 |
|
|
2015
Q2 | $505 | Buy |
383
+273
| +248% | +$360 | ﹤0.01% | 2110 |
|
|
2015
Q1 | $114 | Buy |
+110
| New | +$114 | ﹤0.01% | 3111 |
|